Home NDC 64725-3159 Olanzapine
Product NDC 64725-3159
11-digit product format 647253159
Labeler code 64725
Product ID 64725-3159_5b3c9704-3969-4194-8861-afdf5b27491a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Olanzapine
Dosage form INJECTION, POWDER, FOR SOLUTION
Route INTRAMUSCULAR
Labeler TYA Pharmaceuticals
Application ANDA201588
Marketing category ANDA
Marketing start 2011-10-24
Marketing end 0000-00-00
Substance OLANZAPINE
Active strength 10 mg/2mL
Pharmacologic classes Atypical Antipsychotic [EPC]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 64725-3159-1 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 64725-3159-1 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 64725-3159-1 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 64725-3159-1 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 64725-3159-1 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 64725-3159-1 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 64725-3159-1 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 64725-3159-1 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 64725-3159-1 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 64725-3159-1 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 64725-3159-1 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 64725-3159-1 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 64725-3159-1 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 64725-3159-1 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 64725-3159-1 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 64725-3159-1 fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 64725-3159-1 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 64725-3159-1 bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 64725-3159-1 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 64725-3159-1 e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 64725-3159-1 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 64725-3159-1 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A201588-001 OLANZAPINE OLANZAPINE 10MG/VIAL POWDER / INTRAMUSCULAR AP 2011-10-24
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A201588-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A201588-001 OLANZAPINE 10MG/VIAL POWDER / INTRAMUSCULAR AP 2011-10-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A201588-001 OLANZAPINE 10MG/VIAL INJECTABLE / INTRAMUSCULAR AP 2011-10-24 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 64725-3159-1 Olanzapine 10 mL in 1 VIAL INJECTION, POWDER, FOR SOLUTION 10 2
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded OLANZAPINE ACTIVE INGREDIENT N7U69T4SZR OLANZAPINE INJECTION, POWDER, FOR SOLUTION [TYA PHARMACEUTICALS] 2 OLANZAPINE ACTIVE MOIETY N7U69T4SZR OLANZAPINE INJECTION, POWDER, FOR SOLUTION [TYA PHARMACEUTICALS] 2 HYDROCHLORIC ACID INACTIVE INGREDIENT QTT17582CB OLANZAPINE INJECTION, POWDER, FOR SOLUTION [TYA PHARMACEUTICALS] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X OLANZAPINE INJECTION, POWDER, FOR SOLUTION [TYA PHARMACEUTICALS] 2 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I OLANZAPINE INJECTION, POWDER, FOR SOLUTION [TYA PHARMACEUTICALS] 2 TARTARIC ACID INACTIVE INGREDIENT W4888I119H OLANZAPINE INJECTION, POWDER, FOR SOLUTION [TYA PHARMACEUTICALS] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 64725-3159 OLANZAPINE INJECTION, POWDER, FOR SOLUTION [TYA PHARMACEUTICALS] 2 Legacy NDC, 1 package rows 20140927_3b3bc948-161e-49ee-b67f-4bbb63af23d6.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Status 64725-3159-1 64725315901 10 mL in 1 VIAL 10 ml Historical